Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Intervalo de año de publicación
1.
J Clin Rheumatol ; 22(7): 345-54, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27660931

RESUMEN

OBJECTIVE: The objective of this consensus is to update the recommendations for the treatment of hand, hip, and knee osteoarthritis (OA) by agreeing on key propositions relating to the management of hand, hip, and knee OA, by identifying and critically appraising research evidence for the effectiveness of the treatments and by generating recommendations based on a combination of the available evidence and expert opinion of 18 countries of America. METHODS: Recommendations were developed by a group of 48 specialists of rheumatologists, members of other medical disciplines (orthopedics and physiatrists), and three patients, one for each location of OA. A systematic review of existing articles, meta-analyses, and guidelines for the management of hand, hip, and knee OA published between 2008 and January 2014 was undertaken. The scores for Level of Evidence and Grade of Recommendation were proposed and fully consented within the committee based on The American Heart Association Evidence-Based Scoring System. The level of agreement was established through a variation of Delphi technique. RESULTS: Both "strong" and "conditional" recommendations are given for management of hand, hip, and knee OA and nonpharmacological, pharmacological, and surgical modalities of treatment are presented according to the different levels of agreement. CONCLUSIONS: These recommendations are based on the consensus of clinical experts from a wide range of disciplines taking available evidence into account while balancing the benefits and risks of nonpharmacological, pharmacological, and surgical treatment modalities, and incorporating their preferences and values. Different backgrounds in terms of patient education or drug availability in different countries were not evaluated but will be important.


Asunto(s)
Osteoartritis/terapia , Consenso , Técnica Delphi , Medicina Basada en la Evidencia , Mano , Humanos , Osteoartritis de la Cadera/terapia , Osteoartritis de la Rodilla/terapia , Guías de Práctica Clínica como Asunto
2.
J Clin Rheumatol ; 21(8): 391-7, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26457483

RESUMEN

BACKGROUND: Latin America is a heterogeneous region made up of different populations, cultures, latitudes, altitudes, and immigrants from different areas and ethnic groups. OBJECTIVE: The purpose of this study is to describe the clinical and demographic profile of patients with osteoarthritis (OA) evaluated by a selected group of rheumatologists in 13 Latin American countries. METHODS: A descriptive, observational, cross-sectional study was conducted in 13 Latin American countries of patients with symptomatic OA. Data were collected over a 3-month period using an ad hoc questionnaire to evaluate the clinical and demographic features of OA seen by rheumatologists. RESULTS: Among the 3040 patients, their average age was 62.5 years, and female-to-male ratio was 4.8:1. Patients with body mass index of greater than 30 kg/m or obesity was found in 38.2%. Approximately 88% had primary OA. Joints with OA were as follows: knee 31.2%, hand 9.5%, hand and knee 22.9%, proximal and distal interphalangeal joints (erosive OA) 6.5%, axial 6.6%, and hip 1.3%. Approximately 88.5% had radiographic severity of grade 2 or 3 on Kellgren-Lawrence scale (0-4). Nonsteroidal anti-inflammatory drugs were the predominant OA treatment included in combinations with glucosamine sulfate/chondroitin and viscosupplementation. Associated comorbidities included hypertension (39%), obesity (36.3%), diabetes mellitus (12%), and without comorbidity (12.7%). CONCLUSIONS: This is 1 of the largest population studies that evaluated the characteristics of OA in 3040 patients evaluated by rheumatologists in 13 Latin American countries. This study provides important data for each Latin American country to develop new health care planning in management of OA.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Artrografía/estadística & datos numéricos , Glucosamina/uso terapéutico , Hipertensión/epidemiología , Obesidad/epidemiología , Osteoartritis , Viscosuplementos/uso terapéutico , Comorbilidad , Estudios Transversales , Demografía , Femenino , Humanos , América Latina/epidemiología , Masculino , Persona de Mediana Edad , Osteoartritis/diagnóstico , Osteoartritis/tratamiento farmacológico , Osteoartritis/epidemiología , Osteoartritis/fisiopatología , Índice de Severidad de la Enfermedad
3.
Rev. colomb. reumatol ; 4(4): 164-9, dic. 1997. tab
Artículo en Español | LILACS | ID: lil-293733

RESUMEN

El comportamiento epidemiológico y clínico de la Pandemia Global VIH/SIDA resulta cambiante en diferentes regiones, grupos étnicos y raciales. Sin embargo los mecanismosque obran en sus génesis son comunes. Existe una paulatina y severa depleción de los linfocitos "T" CD (+), con alteraciones de la inmunidad celular y respuesta humoral que conducen a un sinnúmero de manifestaciones y expresiones clínicas entre las cuales se encuetran las musculoesqueléticas y otras de índole reumatológica. Estudiamos una serie anidada en una cohorte de pacientes VIH (+) con manifestaciones reumáticas clasificables como espondiloartropatías seronegativas a la cual caracterizamos en el orden clínico epidemiológico. Constatamos una frecuencia general del 8.6 por ciento, sexo masculino con predominio oligoarticular asimétrico de miembros inferiores y una evolución severa no grave en general; respuesta terapéutica adecuada a las drogas convencionales usadas, en un período de seguimiento de alrededor de 6 meses. Presentamos nuestros datos y una breve reseña comparativa con la literatura publicada


Asunto(s)
Humanos , Síndrome de Inmunodeficiencia Adquirida , VIH , Espondilitis Anquilosante , Artritis Psoriásica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA